Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer
Molecular Pharmaceutics · 05.08.2024 · 21 (8) · 3764-3776
DOI: 10.1021/acs.molpharmaceut.4c00329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.07.2024. Verfasst von Ying Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Microenvironment, Pancreatic Stellate Cells, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: Natural Science Foundation of??Hunan Province, Research Foundation of Education Bureau of Hunan Province.
Abstract (Originalsprache)
Pancreatic cancer remains a formidable challenge in oncology due to its aggressive nature and limited treatment options. The dense stroma surrounding pancreatic tumors not only provides structural support but also presents a formidable barrier to effective therapy, hindering drug penetration and immune cell infiltration. This review delves into the intricate interplay between stromal components and cancer cells, highlighting their impact on treatment resistance and prognosis. Strategies for stromal remodeling, including modulation of cancer-associated fibroblasts (CAFs), pancreatic stellate cells (PSCs) activation states, and targeting extracellular matrix (ECM) components, are examined for their potential to enhance drug penetration and improve therapeutic efficacy. Integration of stromal remodeling with conventional therapies, such as chemotherapy and immunotherapy, is discussed along with the emerging field of intelligent nanosystems for targeted drug delivery. This comprehensive overview underscores the importance of stromal remodeling in pancreatic cancer treatment and offers insights into promising avenues for future research and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China.
- China Quality Mark Certification (Shandong) Co., LTD, Jinan, Shandong 250100, China.
- Hunan Bainianyiren Chinese Traditional Medical Institute Co., LTD, Changsha, Hunan 410221, China.
- Key Laboratory of Biological Nanotechnology of National Health Commission, Changsha, Hunan 410008, China.
ORCID-Profile: Wenhu Zhou
Förderung
- Natural Science Foundation of??Hunan Province
- Research Foundation of Education Bureau of Hunan Province
Zitieren
APA
Zhou, Y., Ma, Y., Sheng, J., Ma, Y., Ding, J., & Zhou, W. (2024). Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer. Molecular Pharmaceutics, 21(8), 3764-3776. https://doi.org/10.1021/acs.molpharmaceut.4c00329
Vancouver
Zhou Y, Ma Y, Sheng J, Ma Y, Ding J, Zhou W. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer. Molecular Pharmaceutics. 2024;21(8):3764-3776. doi:10.1021/acs.molpharmaceut.4c00329
BibTeX
@article{Zhou2024,
author = {Zhou, Ying and Ma, Yunxiao and Sheng, Jianwei and Ma, Yiran and Ding, Jinsong and Zhou, Wenhu},
title = {Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {8},
pages = {3764--3776},
doi = {10.1021/acs.molpharmaceut.4c00329}
}
EUVIMED